Latest news
{{'Thu, 17 Sep 2026 07:00:00 -0400' | dateFormatUsFilter}}
Novo's denecimig demonstrates tolerability after switch from emicizumab in FRONTIER5 study of people with hemophilia A as published in the Journal of Thrombosis and Haemostasis
Read more
{{'Tue, 11 Aug 2026 08:00:00 -0400' | dateFormatUsFilter}}
Novo Nordisk's Awiqli®, the first once-weekly basal insulin for adults with type 2 diabetes, now available in the US
Read more
{{'Tue, 04 Aug 2026 16:12:00 -0400' | dateFormatUsFilter}}
Financial report for the period January 1, 2026 to June 30, 2026
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.